Ascendis Pharma A ASND
NASDAQ ASND
$238.43 +4.10 (+1.75%)
As of: Oct 21, 2026 · 3:38 PM EDT

Ascendis Pharma A (ASND) Common Equity (2012 - 2026)

Updated

Ascendis Pharma A's Common Equity came in at $1.67 billion for the quarter ended Jun 30, 2026, compared with -$212.32 million a year earlier and up 192.3% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Common Equity (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A's Common Equity was -$183.96 million.

  • Going back by year, Common Equity was -$114.41 million in the year ended Dec 31, 2024, -$157.6 million in the year ended Dec 31, 2023, $277.56 million in the year ended Dec 31, 2022 (-72.5%) and $1.01 billion in the year ended Dec 31, 2021 (+1.1%).
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Common Equity in data going back to the quarter ended Dec 31, 2012.
  • The fastest year-over-year change in Common Equity over five years came in the quarter ended Sep 30, 2021 (growth of 5.4%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 89.1%).
  • Business Quant data shows ASND's Common Equity at $571.29 million (quarter ended Mar 31, 2026), -$189.53 million (quarter ended Dec 31, 2025) and -$203.5 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn 84.97 Bn
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn -5.94 Bn
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn 50.37 Bn
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn 11.83 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn 85.49 Bn
10 Ascendis Pharma A 14.45 Bn 10.71 Bn 362.22 Mn 1.64 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.64 Bn
Mar 31, 2026 559.22 Mn
Dec 31, 2025 -191.27 Mn
Sep 30, 2025 -204.24 Mn
Jun 30, 2025 -219.97 Mn
Mar 31, 2025 -205.45 Mn
Dec 31, 2024 -110.00 Mn
Sep 30, 2024 -108.70 Mn
Jun 30, 2024 -343.88 Mn
Mar 31, 2024 -257.10 Mn
Dec 31, 2023 -161.26 Mn
Sep 30, 2023 -77.56 Mn
Jun 30, 2023 70.47 Mn
Mar 31, 2023 182.33 Mn
Dec 31, 2022 280.75 Mn
Sep 30, 2022 443.86 Mn
Jun 30, 2022 634.99 Mn
Mar 31, 2022 750.99 Mn
Dec 31, 2021 1.00 Bn
Sep 30, 2021 1.15 Bn
API Access

Ascendis Pharma A Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ASND&period=max&api_key=YOUR_API_KEY